Skip to main content
ASPI
NASDAQ Industrial Applications And Services

ASPI Subsidiary Noble Africa to Merge with ENDRA Life Sciences, Secures $50M Private Placement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Positive
Importance info
9
Price
$6.375
Mkt Cap
$802.634M
52W Low
$3.92
52W High
$14.49
52W Position info
63% above low
Off High info
56% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

ASPI sits 63% above its 52-week low of $3.92.

Summary

ASP Isotopes' subsidiary, Noble Africa (holding Renergen's helium assets), will merge with ENDRA Life Sciences to become a new Nasdaq-listed entity, Noble Africa Inc. This transaction includes a $50 million private placement, with ASPI investing $20 million, to fund the Virginia Gas Project.


Key Events · M&A and Partnerships · ASPI

  • Strategic Merger Announced

    ASP Isotopes' wholly-owned subsidiary, Noble Africa (which holds Renergen Limited), will merge with a subsidiary of ENDRA Life Sciences Inc. Noble Africa will be the surviving entity and will apply to list on Nasdaq under the ticker 'NOBA'.

  • Significant Private Placement Secured

    Noble Africa has secured commitments for a $50 million private placement. ASP Isotopes is the lead investor, committing $20 million, with other investors (including ASPI management) contributing $30 million.

  • ASPI Retains Majority Ownership

    Upon completion, ASP Isotopes is expected to own approximately 89% of the combined Noble Africa Inc., with pre-closing ENDRA stockholders owning ~3% and other private placement investors ~7%.

  • Funding for Virginia Gas Project

    The financing is intended to provide Noble Africa with the capital structure and funding needed to advance Phase 1 and Phase 2 development of Renergen's Virginia Gas Project, a helium platform.


Analysis · ASPI · Industrial Applications And Services

This filing details a major strategic move by ASP Isotopes to unlock value from its Renergen helium assets by merging its subsidiary, Noble Africa, with ENDRA Life Sciences to create a new, separately listed Nasdaq entity. The concurrent $50 million private placement, with a significant $20 million investment from ASPI itself and additional funds from management, provides crucial capital for the development of the Virginia Gas Project. This transaction addresses the funding needs for a key asset, especially important given ASPI's recent reported losses and cash burn, and aims to provide direct public market exposure to a helium development asset at a time of tightening supply.

At the time of this filing, ASPI was trading at $6.38 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $802.6M. The 52-week trading range was $3.92 to $14.49. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ASPI - Latest Insights

ASPI
Aug 06, 2026, 8:15 AM EDT
Filing Type: 425
Importance Score:
8
Price at Filing: $4.10
Real-time Price: $4.45 info
Change: +$0.350 (+9%) info
Market Cap: $557.752M info
ASPI
Aug 06, 2026, 8:12 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.10
Real-time Price: $4.45 info
Change: +$0.350 (+9%) info
Market Cap: $557.752M info
ASPI
Aug 04, 2026, 5:25 PM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $4.32
Real-time Price: $4.45 info
Change: +$0.130 (+3%) info
Market Cap: $557.752M info
ASPI
Aug 04, 2026, 8:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.26
Real-time Price: $4.45 info
Change: +$0.1878 (+4%) info
Market Cap: $557.752M info
ASPI
Jul 22, 2026, 8:35 AM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $4.24
Real-time Price: $4.45 info
Change: +$0.210 (+5%) info
Market Cap: $557.752M info